Showing results (201-210 of 1,435) with videos related to
Sort By:
Pageof 144
Journal of Pharmaceutical Analysis|April 27, 2023
Drug adulteration analysis based on complexation with cyclodextrin and metal ions using ion mobility spectrometryZhigang Liang, Huanhuan Wang, Fangling Wu, et al.Journal of Pharmaceutical Analysis|July 3, 2020
Current status and future directions of high-throughput ADME screening in drug discoveryWilson Z ShouJournal of Pharmaceutical Analysis|July 3, 2020
Ultra-sensitive bioanalysis of the therapeutic peptide exenatide for accurate pharmacokinetic analyses at effective plasma concentrations utilizing UPLC-MS/MSMax Sauter, Philipp Uhl, Jürgen Burhenne, et al.Journal of Pharmaceutical Analysis|July 3, 2020
Rapid bioluminescence assay for monitoring rat CES1 activity and its alteration by traditional Chinese medicinesJun Zhang, Dandan Wang, Liwei Zou, et al.Journal of Pharmaceutical Analysis|July 3, 2020
An ultra-sensitive and easy-to-use assay for sensing human UGT1A1 activities in biological systemsYa-Di Zhu, Hui-Lin Pang, Qi-Hang Zhou, et al.Journal of Pharmaceutical Analysis|May 14, 2023
High-throughput transcriptional profiling of perturbations by Panax ginseng saponins and Panax notoginseng saponins using TCM-seqJunyun Cheng, Jie Chen, Jie Liao, et al.Journal of Pharmaceutical Analysis|September 13, 2021
Drug repurposing against coronavirus disease 2019 (COVID-19): A reviewLianxiang Luo, Qin Qiu, Fangfang Huang, et al.Journal of Pharmaceutical Analysis|September 13, 2021
Simultaneous determination of fourteen components of Gumiganghwal-tang tablet in human plasma by UPLC-ESI-MS/MS and its application to pharmacokinetic studySeung-Hyun Jeong, Ji-Hun Jang, Guk-Yeo Lee, et al.Journal of Pharmaceutical Analysis|September 13, 2021
Formation mechanisms of sub-micron pharmaceutical composite particles derived from far- and near-field Raman microscopyJakob Hübner, Jean-Baptiste Coty, Yan Busby, et al.Journal of Pharmaceutical Analysis|November 8, 2022
Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infectionWujun Chen, Bing Liang, Xiaolin Wu, et al.Pageof 144